Carbonyl Reduction of Flubendazole in the Human Liver: Strict Stereospecificity, Sex Difference, Low Risk of Drug Interactions
Flubendazole (FLU), an anthelmintic drug of benzimidazole type, is now considered a hbl5266ca promising anti-cancer agent due to its tubulin binding ability and low system toxicity.The present study was aimed at determining more information about FLU reduction in human liver, because this information has been insufficient until now.Subcellular frac